Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.1800 (-3.78%) ($3.1800 - $3.1800) on Tue. Apr. 5, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.78% (three month average) | RSI | 59 | Latest Price | $3.1800(-3.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.5% a day on average for past five trading days. | Weekly Trend | CGEN advances 1.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) SPY(94%) IVW(93%) XBI(91%) XLK(91%) IWO(90%) | Factors Impacting CGEN price | CGEN will decline at least -1.89% in a week (0% probabilities). VXX(-87%) UNG(-29%) TIP(-19%) UUP(-16%) TBT(-10%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.89% (StdDev 3.78%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $3.22 | 5 Day Moving Average | $3.27(-2.75%) | 10 Day Moving Average | $3.27(-2.75%) | 20 Day Moving Average | $3.22(-1.24%) | To recent high | -25.5% | To recent low | 15.6% | Market Cap | $263m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |